Pfizer and BioNTech are preparing to start clinical trials of a version of their Covid-19 vaccine targeting the Delta variant next month, amid fears that existing jabs will offer less protection against the infectious strain spreading quickly across much of the world.
輝瑞(Pfizer)和BioNTech準(zhǔn)備下月對專門針對Delta變種的新冠疫苗開展臨床試驗。人們正在擔(dān)心，現(xiàn)有疫苗對這種在全球各地迅速傳播的強(qiáng)傳染性毒株的保護(hù)力下降。
您已閱讀11%（352字），剩余89%（2885字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務(wù)。